[Response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia]. [electronic resource]
Producer: 20151030Description: 266-9 p. digitalISSN:- 2448-5667
- Adult
- Benzamides -- therapeutic use
- Cross-Sectional Studies
- Dasatinib
- Female
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Piperazines -- therapeutic use
- Protein Kinase Inhibitors -- therapeutic use
- Pyrimidines -- therapeutic use
- Thiazoles -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.